KCa3.1 Contributes to Neuroinflammation and Nigral Dopaminergic Neurodegeneration in Experimental models of Parkinson's Disease
Manikandan Samidurai, Karthick Chennakesavan, Souvarish Sarkar, Emir Malovic, Hai Minh Nguyen, Latika Singh, Anil Kumar, Alyssa Ealy, Chelva Janarthanam, Bharathi N. Palanisamy, Naveen Chandra Kondru, Gary D. Zenitsky, Huajun Jin, Vellareddy Anantharam, Anumantha G. Kanthasamy, , Arthi Kanthasamy
This study shows that inhibiting KCa3.1 channels reduces neuroinflammation and dopaminergic neurodegeneration in Parkinson's disease models.
bioRxiv · Mar 18, 2025 · PreprintNeuroscience